Danielle Cornacchio1, Tommy Chou1, Hayley Sacks2, Donna Pincus3, Jonathan Comer1. 1. Department of Psychology, Mental Health Interventions and Technology (MINT) Program, Florida International University, Miami, Florida. 2. Weill Cornell College of Medicine, New York, New York. 3. Department of Psychology, Center for Anxiety and Related Disorders (CARD), Boston University, Boston, Massachusetts.
Abstract
BACKGROUND: In DSM-5, the agoraphobia core symptom criterion has been revised to require fear about multiple situations from across at least two distinct domains in which escape might be difficult or panic-like symptoms might develop. The present study examined patterns and correlates of the recent change in a sample of anxious youth with symptom presentations consistent with the DSM-IV agoraphobia definition and/or specific phobia (SP) to consider how the recent diagnostic change impacts the prevalence and composition of agoraphobia in children and adolescents. METHOD: Analyses (N = 151) evaluated impairment and correlates of agoraphobic youth who no longer meet the DSM-5 agoraphobia criteria relative to agoraphobic youth who do meet the new DSM-5 criteria. Secondary analyses compared agoraphobic youth not meeting DSM-5 criteria to SP youth. RESULTS: One-quarter of youth with symptom presentations consistent with the DSM-IV agoraphobia definition no longer met criteria for DSM-5 agoraphobia, but showed comparable severity and impairment across most domains to youth who do meet criteria for DSM-5 agoraphobia. Further, these youth showed higher levels of anxiety sensitivity and internalizing psychopathology relative to youth with SP. CONCLUSIONS: A substantial proportion of impaired youth with considerable agoraphobic symptom presentations have been left without a specified anxiety diagnosis by the DSM-5, which may affect their ability to receive and/or get coverage for services and their representation in treatment evaluations. Future DSM iterations may do well to include a "circumscribed" agoraphobia specifier that would characterize presentations of fear or anxiety about multiple situations, but that do not span across at least two distinct situational domains.
BACKGROUND: In DSM-5, the agoraphobia core symptom criterion has been revised to require fear about multiple situations from across at least two distinct domains in which escape might be difficult or panic-like symptoms might develop. The present study examined patterns and correlates of the recent change in a sample of anxious youth with symptom presentations consistent with the DSM-IV agoraphobia definition and/or specific phobia (SP) to consider how the recent diagnostic change impacts the prevalence and composition of agoraphobia inchildren and adolescents. METHOD: Analyses (N = 151) evaluated impairment and correlates of agoraphobic youth who no longer meet the DSM-5 agoraphobia criteria relative to agoraphobic youth who do meet the new DSM-5 criteria. Secondary analyses compared agoraphobic youth not meeting DSM-5 criteria to SP youth. RESULTS: One-quarter of youth with symptom presentations consistent with the DSM-IV agoraphobia definition no longer met criteria for DSM-5 agoraphobia, but showed comparable severity and impairment across most domains to youth who do meet criteria for DSM-5 agoraphobia. Further, these youth showed higher levels of anxiety sensitivity and internalizing psychopathology relative to youth with SP. CONCLUSIONS: A substantial proportion of impaired youth with considerable agoraphobic symptom presentations have been left without a specified anxiety diagnosis by the DSM-5, which may affect their ability to receive and/or get coverage for services and their representation in treatment evaluations. Future DSM iterations may do well to include a "circumscribed" agoraphobia specifier that would characterize presentations of fear or anxiety about multiple situations, but that do not span across at least two distinct situational domains.
Authors: Ronald C Kessler; Shelli Avenevoli; E Jane Costello; Katholiki Georgiades; Jennifer Greif Green; Michael J Gruber; Jian-ping He; Doreen Koretz; Katie A McLaughlin; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Kathleen Ries Merikangas Journal: Arch Gen Psychiatry Date: 2011-12-05
Authors: Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Sharon Smith; Rise B Goldstein; W June Ruan; Bridget F Grant Journal: Psychol Med Date: 2007-03-05 Impact factor: 7.723
Authors: Richard T LeBeau; Daniel Glenn; Betty Liao; Hans-Ulrich Wittchen; Katja Beesdo-Baum; Thomas Ollendick; Michelle G Craske Journal: Depress Anxiety Date: 2010-02 Impact factor: 6.505
Authors: Ronald C Kessler; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Hans-Ullrich Wittchen Journal: Int J Methods Psychiatr Res Date: 2012-08-01 Impact factor: 4.035
Authors: Tommy Chou; Aubrey L Carpenter; Caroline E Kerns; R Meredith Elkins; Jennifer Greif Green; Jonathan S Comer Journal: Depress Anxiety Date: 2016-07-19 Impact factor: 6.505
Authors: Annelieke M Roest; Ymkje Anna de Vries; Carmen C W Lim; Hans-Ulrich Wittchen; Dan J Stein; Tomasz Adamowski; Ali Al-Hamzawi; Evelyn J Bromet; Maria Carmen Viana; Giovanni de Girolamo; Koen Demyttenaere; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; José Miguel Caldas-de-Almeida; Norito Kawakami; Jean Pierre Lépine; Daphna Levinson; Maria E Medina-Mora; Fernando Navarro-Mateu; Siobhan O'Neill; Marina Piazza; José A Posada-Villa; Tim Slade; Yolanda Torres; Ronald C Kessler; Kate M Scott; Peter de Jonge Journal: Depress Anxiety Date: 2019-02-06 Impact factor: 6.505